These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28391726)
21. Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study. Tokmak A; Yıldırım G; Sarıkaya E; Çınar M; Boğdaycıoğlu N; Yılmaz FM; Yılmaz N Rev Bras Ginecol Obstet; 2015 Sep; 37(9):411-6. PubMed ID: 26352944 [TBL] [Abstract][Full Text] [Related]
22. Endogenous sex hormone levels and mammographic density among postmenopausal women. Tamimi RM; Hankinson SE; Colditz GA; Byrne C Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2641-7. PubMed ID: 16284390 [TBL] [Abstract][Full Text] [Related]
23. Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women. Hanna M; Dumas I; Orain M; Jacob S; Têtu B; Sanschagrin F; Bureau A; Poirier B; Diorio C Menopause; 2017 May; 24(5):524-535. PubMed ID: 28002200 [TBL] [Abstract][Full Text] [Related]
27. Women with premature ovarian failure using hormone therapy do not experience increased levels of depression, anxiety and stress compared to controls. Menezes C; Pravata GR; Yela DA; Benetti-Pinto CL J Affect Disord; 2020 Aug; 273():562-566. PubMed ID: 32560954 [TBL] [Abstract][Full Text] [Related]
28. Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study. Soares PM; Cabello C; Magna LA; Tinois E; Benetti-Pinto CL Sao Paulo Med J; 2010 Jul; 128(4):211-4. PubMed ID: 21120432 [TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk factors in relation to breast density (United States). Titus-Ernstoff L; Tosteson AN; Kasales C; Weiss J; Goodrich M; Hatch EE; Carney PA Cancer Causes Control; 2006 Dec; 17(10):1281-90. PubMed ID: 17111260 [TBL] [Abstract][Full Text] [Related]
30. Longitudinal trends in mammographic percent density and breast cancer risk. Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617 [TBL] [Abstract][Full Text] [Related]
31. Prenatal and perinatal correlates of adult mammographic breast density. Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963 [TBL] [Abstract][Full Text] [Related]
32. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Heusinger K; Jud SM; Häberle L; Hack CC; Fasching PA; Meier-Meitinger M; Lux MP; Hagenbeck C; Loehberg CR; Wittenberg T; Rauh C; Wagner F; Uder M; Hartmann A; Schulz-Wendtland R; Beckmann MW; Wachter DL Breast Cancer Res Treat; 2012 Oct; 135(3):885-92. PubMed ID: 22936391 [TBL] [Abstract][Full Text] [Related]
33. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. La Marca A; Marzotti S; Brozzetti A; Stabile G; Artenisio AC; Bini V; Giordano R; De Bellis A; Volpe A; Falorni A; J Clin Endocrinol Metab; 2009 Oct; 94(10):3816-23. PubMed ID: 19622621 [TBL] [Abstract][Full Text] [Related]
34. Breast density scales: the metric matters. Abdolell M; Tsuruda KM; Brown P; Caines JS; Iles SE Br J Radiol; 2017 Oct; 90(1078):20170307. PubMed ID: 28707989 [TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332 [TBL] [Abstract][Full Text] [Related]
36. Premature ovarian insufficiency: the context of long-term effects. Podfigurna-Stopa A; Czyzyk A; Grymowicz M; Smolarczyk R; Katulski K; Czajkowski K; Meczekalski B J Endocrinol Invest; 2016 Sep; 39(9):983-90. PubMed ID: 27091671 [TBL] [Abstract][Full Text] [Related]
37. Pulse wave velocity and myocardial performance index in premature ovarian insufficiency. Aksoy MN; Akdemir N; Kilic H; Yilmaz S; Akdemir R; Gunduz H Scand Cardiovasc J; 2017 Apr; 51(2):95-98. PubMed ID: 28098488 [TBL] [Abstract][Full Text] [Related]
38. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953 [TBL] [Abstract][Full Text] [Related]
39. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735 [TBL] [Abstract][Full Text] [Related]
40. Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Kelemen LE; Pankratz VS; Sellers TA; Brandt KR; Wang A; Janney C; Fredericksen ZS; Cerhan JR; Vachon CM Am J Epidemiol; 2008 May; 167(9):1027-36. PubMed ID: 18385204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]